FDA Approved: XIFAXAN — Supplemental Application (Salix Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for XIFAXAN (rifaximin) filed by Salix Pharmaceuticals, Inc., resulting in an update to the product's approval via a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Irritable Bowel Syndrome with Diarrhea
• Traveler Diarrhea

Drugs mentioned

• XIFAXAN (rifaximin)

Snippet

SUPPL AP for XIFAXAN (RIFAXIMIN)